OUR MISSION
is to reinvent surgical education by utilising technological and didactic innovations providing the most realistic training simulations. We are building an eco-system for the surgical community in line with highest compliance conformity and addressing the needs & values of the new generation of surgeons.
WHAT DO WE DO?
The Rimasys Group is a technology-driven health-tech company, based in Cologne, Germany, and channels its activities through three brands, online and offline products, services, events, and platforms, and reaches medical communities all over the world. Our core products are lifelike fractured anatomical specimens with closed soft tissue mantle, generated using proprietary biomechanical algorithms that describe injury mechanisms. We are focusing on enhancing surgical education and improving patient outcomes by advancing practical skill training and medical device development. Our family of brands is creating innovation focused on digital health and education.
OUR MISSION
is to reinvent surgical education by utilizing technological and didactic innovations providing the most realistic training simulations. We are building an eco-system for the surgical community in line with the highest compliance conformity and addressing the needs & values of the new generation of surgeons.
LEADERSHIP TEAM
Miriam Stadthalter
Chief Executive Officer
(CEO)
Dr. Henning Roet de Rouet
Chief Operating Officer
(COO)
Jan Jennes
Chief Financial Officer
(CFO)
Rimasys Group sets new standards in surgical education and the MedTech industry through realistic high-fidelity training and interactive solutions. Partnerships with hospital chains, global organizations, and medical societies will drive the adoption and advancement in the next generation's surgical community.
The constant advancement of our innovations offers new possibilities in surgical simulation and digital health. We aim to support surgeons not only during training but also in preparing for the operating room to create a thriving ecosystem for healthcare professionals.
We'll continue to challenge the status quo to ultimately improve quality of care and patient outcomes.